Axon Enterprise, Inc (NASDAQ:AXON) Shares Acquired by Lee Johnson Capital Management LLC

Lee Johnson Capital Management LLC boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 2,032.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,294 shares of the biotechnology company's stock after purchasing an additional 6,952 shares during the quarter. Axon Enterprise makes up 2.0% of Lee Johnson Capital Management LLC's holdings, making the stock its 15th largest position. Lee Johnson Capital Management LLC's holdings in Axon Enterprise were worth $3,836,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of AXON. Fourth Dimension Wealth LLC purchased a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $30,000. Bartlett & CO. Wealth Management LLC lifted its position in shares of Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after acquiring an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new position in shares of Axon Enterprise in the first quarter valued at approximately $32,000. Alpine Bank Wealth Management purchased a new position in shares of Axon Enterprise in the first quarter valued at approximately $40,000. Finally, Elequin Capital LP purchased a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $46,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insider Activity at Axon Enterprise

In other news, Director Michael Garnreiter sold 5,913 shares of Axon Enterprise stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $760.00, for a total value of $4,493,880.00. Following the completion of the sale, the director directly owned 17,740 shares of the company's stock, valued at approximately $13,482,400. The trade was a 25.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction on Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the completion of the sale, the chief accounting officer directly owned 15,240 shares of the company's stock, valued at $11,762,384.40. The trade was a 0.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 44,642 shares of company stock valued at $30,500,428 over the last 90 days. Corporate insiders own 5.70% of the company's stock.

Axon Enterprise Trading Up 1.6%

AXON stock traded up $12.27 during midday trading on Wednesday, hitting $802.49. 98,507 shares of the company's stock were exchanged, compared to its average volume of 700,596. The business has a 50-day simple moving average of $744.55 and a two-hundred day simple moving average of $638.37. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $62.47 billion, a PE ratio of 193.84, a P/E/G ratio of 92.34 and a beta of 1.29. Axon Enterprise, Inc has a 1-year low of $279.02 and a 1-year high of $830.21.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The firm's quarterly revenue was up 31.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.15 earnings per share. On average, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Needham & Company LLC raised their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Wolfe Research assumed coverage on Axon Enterprise in a research report on Monday. They issued an "outperform" rating on the stock. Bank of America raised their target price on Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Finally, Barclays lifted their price objective on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $699.55.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.